Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-04 Purchase | 2023-08-07 5:11 pm | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 21,880 | $22.93 | $501,794 | 21,880 (Direct) | View |
| 2021-09-14 Sale | 2021-09-14 7:29 pm | Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO | 71,833 | $38 | $2,729,654 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-01 Disposition | 2024-08-05 4:20 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 222,723 | $0 | 0 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:37 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 81,065 | $0 | 81,065 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:26 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 23,847 | $0 | 45,727 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-06 4:16 pm | N/A 2033-07-03 | Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks | 119,778 | $0 | 119,778 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-09 8:23 pm | N/A 2031-03-09 | Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO | 90,000 | $0 | 90,000 (Direct) | View |
| 2020-03-03 Option Award | 2020-03-05 7:49 pm | N/A 2030-03-02 | Translate Bio Inc. | TBIO | Burgess Paul D. Chief Operating Officer, CLO | 150,000 | $0 | 150,000 (Direct) | View |